The list for 2022 featured 11 start-up companies from India along with 19 companies from Singapore, followed by 16 start-ups from Hong Kong, 15 from South Korea, and 13 from China.
The cervical cancer vaccine, Cervavac, is a Quadrivalent Human Papillomavirus vaccine (qHPV)developed by the Serum Institute of India (SII) and the Department of Biotechnology (DBT).
EXAMIANS